Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71610-163
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-163). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure-01 (Figure 01)
Figure-02 (Figure 02)
The text seems to be a graph or table showing the "Cumulative Hazard (%)" on the y-axis, with values of 10 and 15 marked, and "Time to First Primary Endpoint Through Four (4) Years of Followup (Years)" on the x-axis, with values 1 to 5 marked. The word "Atorvastatin" is mentioned and there is an equation with HR 0.53. Not enough context is available to generate a useful description.*
Figure-03 (Figure 03)
The text consists of a table that shows the percentage of subjects experiencing E vert with different doses of Horvastatin and Sorvastatin. The text also includes a HR value with a Confidence interval and a P-value. Furthermore, there is a mention of Time to First Major Cardiovascular Endpoint in years.*
Chemical-structure (Chemical Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.